Huami Partnered with Nanshan Zhong’s Team to Combat COVID-19 Coronavirus on a Joint Lab

SHENZHEN, China, April 10, 2020 /PRNewswire/ — Huami (NYSE: HMI), announced a collaboration with China National Clinical Research Center of Respiratory Disease (NCRCRD) and Guangdong Nanshan Medical Innovation Institute, led by Dr. Nanshan Zhong, to establish a smart wearable joint laboratory. Based on Huami smart wearable technology and powerful computing algorithms, the lab aims to help COVID-19 recovered patients’ follow-up care and management through the NCRCRD big data platform. Moreover, the lab would jointly contribute to an epidemic prediction and alert system.

“As the collaboration among medical institutions, R&D institutions and enterprises, we are excited to leverage our expertise in smart wearable technology to promote applied research and transformation achievements of respiratory health,” said Wang Huang, Founder, Chairman and CEO of Huami Technology. Driven by the mission of Connect Health with Technology, Huami is committed to establishing a global health ecosystem including device, data and service, while being the most trusted partner of its users.

Dr. Nanshan Zhong, aged 83, an international famed respiratory disease specialist and academician of Chinese Academy of Engineering, was a pioneer in the SARS control in 2013 and is now the leader of the senior experts of COVID-19 prevention with China’s National Health Commission. Dr. Nanshan Zhong has been fighting at the frontline of the coronavirus outbreak since reporting the person-to-person transmission of COVID-19 in January.

Since the coronavirus outbreak, Huami has continued the efforts of Connect Health with Technology. The company has donated medical supplies and devices worth 11.5million RMB since the COVID-19 epidemic outbreak. Huami has also developed a smartwatch for medical staff in Wuhan, with a feature to ease psychological distress. 

 

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/huami-partnered-with-nanshan-zhongs-team-to-combat-covid-19-coronavirus-on-a-joint-lab-301038748.html

SOURCE Huami

Staff

Recent Posts

Castle Biosciences Announces Updates to its Board of Directors

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that…

7 hours ago

Akanda Corp. Announces Closing of Underwritten Public Offering

London, United Kingdom--(Newsfile Corp. - March 27, 2024) - On March 24, 2024, Akanda Corp.…

7 hours ago

Dermata to Present at the Emerging Growth Conference on April 3, 2024

- Dermata to provide a corporate update followed by a live question and answer session…

7 hours ago

CorDx Receives Emergency Use Authorization (EUA) for 10-Min Flu A/B & COVID-19 Test

FDA Grants CorDx Emergency Use Authorization for Multi-Target Rapid Test for Flu A/B & COVID-19SAN…

10 hours ago

Greenway Health and DrFirst Partner to Improve Medication Adherence and Improve Patient Outcomes through Technology

TAMPA, Fla., March 27, 2024 /PRNewswire/ -- Greenway Health, a leading health information technology services provider, announced its strategic…

13 hours ago

NextGen Healthcare Named to Newsweek List of America’s Most Trustworthy Companies for Third Year in a Row

List Based on an Independent Survey of 25,000 U.S. ResidentsREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, a…

13 hours ago